Transarterial embolization in inflammatory arthritis: will rheumatology shape the debate or inherit it?

Clicks: 26
ID: 331758
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #31 of 143 articles by views in Rheumatology Advances in Practice

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 143 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract The expanding use of transarterial embolization for musculoskeletal pain, most commonly operationalized as genicular artery embolization in osteoarthritis, raises a broader question that rheumatology has not yet systematically addressed: might a vessel-targeted, image-guided intervention complement pharmacological care in selected patients with inflammatory arthritis? Despite advances in treat-to-target strategies, a single persistently inflamed joint can remain the dominant source of pain and disability while composite disease activity scores indicate target achievement. When that joint is refractory and systemic escalation is either disproportionate or infeasible, the therapeutic options are narrow and poorly evidenced. This review argues that the rheumatology community should be defining where, when, and for whom transarterial embolization might have a legitimate place–its positioning within the inflammatory arthritis therapeutic landscape–rather than allowing this to be shaped, by default, through fragmented case-based experience and a literature centred predominantly outside the discipline. Drawing on the neurovascular biology of synovitis, the osteoarthritis evidence, and emerging reports in inflammatory conditions, we map the scenarios in which the question is starting to surface and outline what a deliberate positioning effort would require. In doing so, we recognise that no prospective, randomised, or disease-specific data currently support transarterial embolization in this setting, and that the available signal is limited to isolated case reports. However, defining a shared language now, before uncritical diffusion occurs, is a prerequisite for responsible investigation.
Reference Key
openalex_W7220925314 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Francesco Ursini, Jacopo Ciaffi, Giancarlo Facchini, Piero Ruscitti, Roberto Felice Caporali, Joel A. Block
Are you one of these authors? Claim your profile
Journal Rheumatology Advances in Practice
Year 2026
DOI
10.1093/rap/rkag125
URL
https://doi.org/10.1093/rap/rkag125
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.